2022-2023年希腊流感疫苗对医护人员缺勤的保护效果
本研究前瞻性随访希腊四家三级医院5752名医护人员,评估2022-2023年流感疫苗对流感相关缺勤的保护效果。研究期间共发生1029次缺勤事件,其中流感相关95次(9.2%)。未调整疫苗保护效果为48.9%(95%CI 6.1%-71.1%,P=0.03),调整后为69.9%(95%CI 39.3%-85.1%,P=0.001)。结论认为接种流感疫苗对医护人员流感相关缺勤具有显著保护作用。
要点
- 流感相关缺勤平均3.6天,非流感相关缺勤平均5.4天(P<0.001)。
- 医护人员流感疫苗接种率为23.1%(1332/5752)。
- 调整后流感疫苗对流感相关缺勤的保护效果为69.9%(95%CI 39.3%-85.1%)。
核心结论
- 流感仍是后新冠时代医护人员发病和缺勤的重要原因。
- 接种疫苗对2022-2023年流感季医护人员流感相关缺勤具有显著保护作用。
- 医护人员应及时接种流感疫苗以保护自身并减少医疗机构缺勤。
研究设计与样本
- 前瞻性随访研究,纳入希腊四家三级医院的5752名医护人员,随访时间为2022年11月14日至2023年5月28日。
- 出现症状的医护人员通过RT-PCR和/或快速抗原检测进行流感及SARS-CoV-2感染检测。
主要发现
- 研究期间共发生1029次缺勤事件,其中流感相关95次(9.2%)。
- 流感相关缺勤平均每次3.6天,非流感相关缺勤平均每次5.4天(P<0.001)。
- 流感相关缺勤导致341天缺勤,占研究期间总缺勤天数5360天的一部分。
- 1332名医护人员接种了2022-2023季流感疫苗,接种率为23.1%。
- 未调整的流感疫苗对流感相关缺勤的保护效果为48.9%(95%CI 6.1%-71.1%,P=0.03);调整年龄、性别、合并症、职业、流感疫苗接种、COVID-19疫苗接种及医院水平变异后,调整保护效果为69.9%(95%CI 39.3%-85.1%,P=0.001)。
临床怎么用
- 医护人员应及时接种流感疫苗,以保护自身并减少医疗机构因医护人员缺勤造成的影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To estimate the influenza vaccine effectiveness (IVE) against absenteeism among healthcare personnel (HCP) during the 2022-2023 season. METHODS: We prospectively followed 5752 HCP employed in four tertiary-care hospitals in Greece from November 14, 2022 to May 28, 2023 for episodes of absenteeism. Upon onset of symptoms, HCP were tested for influenza and SARS-CoV-2 infection by RT-PCR and/or rapid antigen detection test. RESULTS: A total of 1029 episodes of absenteeism occurred during the study period. Influenza accounted for 95 (9.2 %) of episodes. The mean duration of work absence per influenza-related episode of absenteeism was 3.6 days compared to a mean of 5.4 days per other non-influenza-related episode of absenteeism (p-value <0.001). Influenza accounted for 341 days missed out of a total of 5360 days missed during the study period. Overall, 1332 HCP had received an influenza vaccine for the 2022-2023 season (influenza vaccination rate: 23.1 %). The unadjusted IVE estimate against influenza-related absenteeism among all HCP was 48.9 % [95 % confidence intervals (CIs): 6.1 % to 71.1 %; p-value = 0.03]. After controlling for age, sex, comorbidities, profession, influenza vaccination, COVID-19 vaccination, and hospital-level variation, the adjusted IVE among HCP with absenteeism was estimated at 69.9 % (95 % CIs, 39.3 % to 85.1 %, p-value = 0.001). CONCLUSIONS: Influenza remains a significant cause of morbidity and absenteeism among HCP in the post-COVID era. Vaccination conferred significant protection against influenza-associated absenteeism among HCP during the 2022-2023 season. HCP should be up to date with influenza vaccination to protect them as well as healthcare facilities from HCP absenteeism.
引用
- Maltezou HC, Gamaletsou MN, Giannouchos TV, et al. Influenza vaccine effectiveness against absenteeism among healthcare personnel during the 2022-2023 season in Greece. Vaccine. 2025. PMID: 40675109. doi:10.1016/j.vaccine.2025.127468
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。